Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, developing cell replacement therapies to treat serious medical conditions in the United States and internationally. The company develops OpRegen, an allogeneic retinal pigment epithelium cell replacement therapy, which is in...
24 insider purchases on record · latest filing 2026-03-12.
Insiders have also filed 7 sale transactions at LCTX.